Cargando…
Ets-1 expression and gemcitabine chemoresistance in pancreatic cancer cells
Gemcitabine, a novel pyrimidine nucleoside analog, has become the standard chemotherapeutic agent for pancreatic cancer patients. The clinical impact of gemcitabine remains modest owing to the high degree of inherent and acquired resistance. There are various lines of evidence that confirm the role...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SP Versita
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276009/ https://www.ncbi.nlm.nih.gov/pubmed/21225469 http://dx.doi.org/10.2478/s11658-010-0043-z |